跳至主要内容
临床试验/CTRI/2026/03/105113
CTRI/2026/03/105113尚未招募2 期

Single centric Phase II open clinical trial in Soothaga Vaayu (Polycystic Ovarian Disease) with siddha medicine Bojana Kudori Mathirai

Dr V MAHALAKSHMI SWAATHY1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2026年3月23日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
43
试验地点
1

研究概览

简要总结

This is Signal centric phase 2 open clinical trial in SOOTHAGA VAAYU (POLYCYSTIC OVARIAN DISEASE) with siddha medicine BOJANA KUDORI MATHIRAI

The dosage of BOJANA KUDORI MATHIRAI is Sundaikai Alavu (798 mg)

Outcome is mainly assessed by Disappearance/reduction in the size or number of cysts in ultrasonogram(Abdomen and pelvis)

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Polysystic appearance of ovaries (Unilateral/Bilateral).

排除标准

  • Previous K/C/H/O of Endocrine disease Previous K/C/H/O of any serious systemic illness.

研究者

发起方
Dr V MAHALAKSHMI SWAATHY
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr V MAHALAKSHMI SWAATHY

GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI

研究点 (1)

Loading locations...

相似试验